Braeburn

Braeburn is a company dedicated to delivering solutions for people living with the serious consequences of opioid use disorder (OUD). Founded in 2012, the company's slogan, "We transform the management of OUD to help people begin and sustain recovery," defines its mission to challenge the status quo and champion transformation in OUD management. Braeburn partners with the community to ensure that every person with OUD receives the best possible care and opportunity to reach their full potential.

Braeburn's commitment to collaboration, passion, and purpose is evident in its culture, which values authenticity and strives to amplify all voices. The company empowers everyone to contribute to its purpose and unleash their full potential. Braeburn operates in the Health Care and Pharmaceutical industries, with its headquarters in the United States.

In January 2018, Braeburn secured a $110.00M Debt Financing investment from a consortium of prominent investors, including New Leaf Venture Partners, RA Capital Management, Apple Tree Partners, Avista Capital Partners, Rock Springs Capital, Deerfield Capital Management, and Wellington Capital Management.

For more information about Braeburn, please visit www.braeburnrx.com. For community guidelines, please visit this link.